APIC CEO Steps Down, Joins BD

Comments
Print

WASHINGTON—Association for Professionals in Infection Control and Epidemiology (APIC) said Aug. 24 that CEO Kathy Warye has resigned.

Warye has been APIC’s CEO since 2004. The resignation will be effective Oct. 31.

APIC’s board of directors has actively begun a national search for a CEO, and expects to complete this transition within a period of six months.

In November, Warye will join medical-technology company BD (Becton, Dickinson and Company) as vice president, Infection Prevention. In this new role, she will work with thought leaders across the healthcare continuum, throughout the world, to advance best practice in the reduction of healthcare-associated infections.  

During Warye’s tenure, APIC doubled in size and became a key advisor to federal and state governments and more than 30 healthcare organizations, according to APIC.

She was recently ranked #46 among the 100 Most Powerful People in Healthcare by Modern Healthcare magazine.

"APIC members, staff and associates congratulate Kathy on this significant personal achievement,” said APIC 2010 President Cathryn Murphy, RN, PhD, CIC. “Under her management, APIC has become a world leader in infection prevention. We are a stronger, more strategic and more successful organization for having had her lead our team. Her transition to a senior global leadership role within the healthcare industry demonstrates the respect with which APIC is held by key healthcare stakeholders around the world.”

Comments